OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 20 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,465,000 | +1.7% | 5,210,000 | 0.0% | 0.02% | +18.8% |
| Q3 2016 | $1,441,000 | -34.5% | 5,210,000 | 0.0% | 0.02% | -30.4% |
| Q2 2016 | $2,200,000 | +2.4% | 5,210,000 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $2,149,000 | -30.8% | 5,210,000 | 0.0% | 0.02% | -17.9% |
| Q4 2015 | $3,104,000 | -14.3% | 5,210,000 | 0.0% | 0.03% | -24.3% |
| Q3 2015 | $3,621,000 | -25.9% | 5,210,000 | 0.0% | 0.04% | +2.8% |
| Q2 2015 | $4,884,000 | -19.5% | 5,210,000 | 0.0% | 0.04% | -30.8% |
| Q1 2015 | $6,066,000 | -19.5% | 5,210,000 | -30.5% | 0.05% | -27.8% |
| Q4 2014 | $7,538,000 | – | 7,500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $3,550,000 | 0.43% |
| Telemetry Investments, L.L.C. | 2,500,000 | $875,000 | 0.33% |
| UBS OCONNOR LLC | 7,500,000 | $2,780,000,000 | 0.05% |